Our leadership team

Mr. Ziv Turner

Chairman & CEO

Mr. Shmuel De-Saban

CFO and board member

Dr. Med. Yehuda Baruch

Chief Medical and Regulatory Officer​

Mr. Amir Ohad

Financial advisor to the board

Mr. Zvi Riterband

Financial advisor to the board

Dr. Gila Shimoni

Patents Advisor to the Board

Close Menu

Dr. Stanley Hirsch


Dr. Hirsch joined OWCP as Chairman of our Board of Directors in July 2017. He has had extensive scientific, executive and board level experience for more than 25 years in private and publicly listed companies in biopharmaceutical and agricultural biotech industries, inter alia, including direct experience in raising capital and leading M&A activity. This experience, together with his multi-cultural management skills, having managed companies in Israel, Brazil, UK, China and the United States, is directly relevant to OWCP’s scientific and business development efforts.

Dr. Hirsch has served as Group CEO of FuturaGene Limited and its predecessor company, FuturaGene Plc., since 2007. He has also served as Chairman of the Board of Directors of Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), since 2016.

Dr. Hirsch holds a D. Phil (1982) in Cell Biology and Immunology from Oxford University, UK. His educational experience also includes a B.Sc. degree with Honors in Medical Biochemistry from the University of Cape Town, South Africa (1979) among other academic honors and awards from Oxford University and University of Cape Town.